heart failure tagged posts

The risk of developing chronic kidney disease (CKD) or heart failure (HF), or dying, following a type 2 diabetes (T2D) diagnosis increases substantially over time, according to new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2.

The study, which analyzed data from more than 1.6 million patients across the U.S., found that the combined risk of developing CKD or HF, or dying, was 33% on average within the first five years of a T2D diagnosis, rising to 55% over 10 years.

The researchers say their findings underscore the importance of early, proactive and more holistic approaches to managing type 2 diabetes to help reduce the risk of serious complications...

Long-term melatonin use may secretly strain the heart—raising the risk of failure, hospitalization, and death. Long-term melatonin use for sleep problems may come with unexpected heart dangers. Researchers found that chronic users were almost twice as likely to die and 3.5 times more likely to be hospitalized for heart failure. Though melatonin is widely regarded as harmless, experts now urge caution with extended use.

Key Research Findings

A large review of health data from more than 130,000 adults with insomnia found that people who took melatonin for a year or longer were more likely to develop heart failure, be hospitalized for the condition, or die from any cause compared to those who didn’t take the supplement.
While the study cannot prove that melatonin directly causes t...

An international research team found evidence that heart muscle can regenerate after heart failure in some people with artificial hearts. A research team co-led by a physician-scientist at the University of Arizona College of Medicine — Tucson’s Sarver Heart Center found that a subset of artificial heart patients can regenerate heart muscle, which may open the door to new ways to treat and perhaps someday cure heart failure. The results were published in the journal Circulation.

According to the Centers for Disease Control and Pr...

Cleveland Clinic researchers have made a significant discovery about how the gut microbiome interacts with cells to cause cardiovascular disease. The study published in Nature Communications found that phenylacetylglutamine (PAG), produced by gut bacteria as a waste product, then absorbed and formed in the liver, interacts with previously undiscovered locations on beta-2 adrenergic receptors on heart cells once it enters the circulation.

PAG was shown to interact with beta-2 adrenergic receptors to influence how forcefully the heart muscle cells contract—a process that investigators believe contributes to he...